Ross A. Jaffe MD - 10 Jun 2022 Form 4 Insider Report for MINERVA SURGICAL INC

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 10 Jun 2022
Net transaction value: +$119,999
SEC form: 4
Accepted by SEC: 14 Jun 2022, 15:14:22 UTC
Prior SEC filing: 08 Dec 2021
Source filing: View source filing
Reporting owner signature: Lenka Schvaigerova, Attorney-in-fact for Ross A Jaffe MD

Key filing fact

Ross A. Jaffe MD filed Form 4 for MINERVA SURGICAL INC on 14 Jun 2022.

Key facts

This page summarizes Ross A. Jaffe MD's Form 4 filing for MINERVA SURGICAL INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Jun 2022, 15:14.

Change

Previous filing in this sequence was filed on 08 Dec 2021.
Current net transaction value: +$119,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTRS transaction

Common Stock

Award

Transaction value: $119,999
Shares: +49,792
Change %
Price: $2.41^*
Shares after: 49,792
Date: 10 Jun 2022
Ownership: Direct
Footnotes: F1

UTRS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,663,227
Date: 10 Jun 2022
Ownership: See Footnote 2
Footnotes: F2

UTRS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,473
Date: 10 Jun 2022
Ownership: See Footnote 3
Footnotes: F3

UTRS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 94,755
Date: 10 Jun 2022
Ownership: See Footnote 4
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. Each RSU award will vest in four equal quarterly installments on the quarterly anniversary of the grant date, subject to the Reporting Person continuing as a service provider through each such date.

Footnote F2

The securities are held by Versant Venture Capital IV, L.P. ("Versant IV"). Versant Ventures IV, LLC ("Versant Ventures IV GP") is the general partner of Versant IV. The Reporting Person is a managing director of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant IV; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.

Footnote F3

The securities are held by Versant Side Fund IV, L.P. ("Versant Side Fund IV"). Versant Ventures IV GP is the general partner of Versant Side Fund IV. The Reporting Person is a managing director of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.

Footnote F4

The securities are held by The Jaffe Family Trust dtd 7/9/91 of which Ross A Jaffe is a trustee.